Company Profile

Algernon is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.

Latest Presentation

Industry Classifications

Sector:
Biotechnology

Industry:
Drug Development

NAICS:
Research and Development in the Physical, Engineering, and Life Sciences (541710)

SIC:
Commercial Physical and Biological Research (8731)

Contact Information

Investor Relations
Christopher Moreau
Chief Executive Officer
T: 604-398-4175
chris@algernonpharmaceuticals.com

Transfer Agent
TSX Trust Company
1066 W. Hastings Street
Suite 1600
Vancouver, BC V6E 3X1
Canada
T: 604-235-3700
inquiries@astfinancial.com

Company Contact
Algernon Pharmaceuticals Inc.
1055 West Georgia Street
Suite 1500
Vancouver, BC V6E 4N7
Canada
T: 604-398-4175
info@algernonpharmaceuticals.com